PLRX · NASDAQ · Biotechnology

Pliant Therapeutics (PLRX)

Develops integrin-targeted medicines and delivery technologies after its fibrosis-program reset.

$1.12
After hours+0.00 (+0.42%)
At close$1.12(−1.75%)